Global to push GA events into
skip to main content

Title: Biomarkers for lymphoma

A biomarker, method, test kit, and diagnostic system for detecting the presence of lymphoma in a person are disclosed. The lymphoma may be Hodgkin's lymphoma or non-Hodgkin's lymphoma. The person may be a high-risk subject. In one embodiment, a plasma sample from a person is obtained. The level of at least one protein listed in Table S3 in the plasma sample is measured. The level of at least one protein in the plasma sample is compared with the level in a normal or healthy subject. The lymphoma is diagnosed based upon the level of the at least one protein in the plasma sample in comparison to the normal or healthy level.
Inventors:
;
Issue Date:
OSTI Identifier:
1154935
Assignee:
Battelle Memorial Institute (Richland, WA) PNNL
Patent Number(s):
8,822,164
Application Number:
13/690,073
Contract Number:
AC05-76RLO1830
Research Org:
Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Sponsoring Org:
USDOE
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Other works cited in this record:

Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma
journal, March 2011

Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patients
journal, January 1980

Similar records in DOepatents and OSTI.GOV collections: